U OF UTAH NEUROPSYCHIATRIC INSTITUTE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $44.6M
- Transactions
- 4,464
- Companies
- 40
- Average per transaction
- $9,992
Who reported the payments
| Genentech, Inc. | $7,042,891 |
| E.r. Squibb & Sons, L.L.C. | $3,307,981 |
| Gilead | $3,273,974 |
| Eli Lilly | $3,088,547 |
| Exelixis Inc. | $2,603,496 |
| Seagen Inc. | $2,415,436 |
| AbbVie | $2,399,057 |
| Novartis | $2,160,093 |
| Amgen | $1,604,926 |
| Servier Bioinnovation | $1,376,479 |
| Bayer | $1,220,336 |
| Roche Products Limited | $1,130,580 |
| Bristol Myers Squibb | $1,125,476 |
| Incyte Corporation | $1,060,080 |
| Janssen Research & Development, LLC | $1,013,257 |
| Pharmaessentia USA Corporation | $1,006,408 |
| Boehringer Ingelheim | $940,363 |
| Alnylam Pharmaceuticals Inc. | $633,661 |
| Sanofi | $601,236 |
| Amicus Therapeutics, Inc. | $396,028 |
| Intercept Pharmaceuticals, Inc. | $350,846 |
| Sanofi US Services Inc. | $345,028 |
| Karyopharm Therapeutics Inc. | $316,212 |
| Neurocrine Biosciences, Inc. | $307,500 |
| Hoffmann-la Roche Limited | $292,879 |
| Sun Pharmaceutical Industries Inc. | $288,570 |
| Morphosys AG | $275,646 |
| Edwards Lifesciences | $263,359 |
| Dompe Farmaceutici S.p.a. | $225,358 |
| Modernatx, Inc. | $193,869 |
| F. Hoffmann-la Roche AG | $193,158 |
| ADC Therapeutics America, Inc. | $151,538 |
| Medical Device Business Services, Inc. | $143,509 |
| Mitsubishi Tanabe Pharma Development America, Inc. | $128,418 |
| Biomerieux Inc | $126,618 |
| Springworks Therapeutics, Inc. | $119,840 |
| Dentsply IH AB | $119,596 |
| Biosense Webster, Inc. | $112,000 |
| Medtronic | $110,100 |
| Halozyme Inc | $102,218 |